DIFFERENTIAL REGULATION OF IGA PRODUCTION BY TGF-BETA AND IL-5 - TGF-BETA INDUCES SURFACE IGA-POSITIVE CELLS BEARING IL-5 RECEPTOR, WHEREAS IL-5 PROMOTES THEIR SURVIVAL AND MATURATION INTO IGA-SECRETING CELLS

被引:75
作者
SONODA, E
HITOSHI, Y
YAMAGUCHI, N
ISHII, T
TOMINAGA, A
ARAKI, S
TAKATSU, K
机构
[1] KUMAMOTO UNIV,SCH MED,INST MED IMMUNOL,DEPT BIOL,2-2-1 HONJO,KUMAMOTO 860,JAPAN
[2] MITSUBISHI KASEI CO,RES CTR,BIOSCI LAB,YOKOHAMA 227,JAPAN
[3] KUMAMOTO UNIV,SCH MED,DEPT MED 1,KUMAMOTO 860,JAPAN
关键词
D O I
10.1016/0008-8749(92)90184-Q
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Transforming growth factor β (TGF-/3) and IL-5 have been shown to augment IgA production by LPS-stimulated murine B cells. We investigated the effect of TGF-β on the expression of surface Ig-isotype and IL-5 receptor on LPS-stimulated B cells. TGF-β increased the proportion of both surface IgA-positive (sIgA+) B cells and sIgG2b+ B cells and enhanced IgA and IgG2b production by LPS-stimulated B cells. TGF-β synergized with IL-5 only for IgA production of the seven Ig-isotypes and in combination with IL-5 caused a significant increase in the proportion of sIgA+ B cells up to 17.4%. In contrast, IL-5 decreased the proportion of sIgG2b+ B cells and sIgG3+ B cells and inhibited the production of IgG2b and IgG3 by LPS-stimulated B cells. About 50% of sIgA+ cells induced by TGF-β expressed IL-5 receptor. They secreted peak levels of IgA and seemed to maintain long viability in the presence of IL-5; whereas TGF-β had the opposite effects on sIgA+ B cells and down-regulated the IL-5 receptor expression. These results indicate that TGF-β increases the number of sIgA+- and IL-5 receptor-positive B cells which respond to IL-5 giving rise to IgA-secreting cells and also support the notions that TGF-β preferentially induces switching to sIgA+ B cells and IL-5 induces the maturation of postswitch sIgA+ B cells into IgA-secreting cells in a stepwise fashion. © 1992.
引用
收藏
页码:158 / 172
页数:15
相关论文
共 36 条
[1]   CD20 POSITIVE HUMAN LYMPHOCYTES-B SEPARATED WITH THE MAGNETIC CELL SORTER (MACS) CAN BE INDUCED TO PROLIFERATION AND ANTIBODY SECRETION INVITRO [J].
ABTS, H ;
EMMERICH, M ;
MILTENYI, S ;
RADBRUCH, A ;
TESCH, H .
JOURNAL OF IMMUNOLOGICAL METHODS, 1989, 125 (1-2) :19-28
[2]   EXPRESSION AND SECRETION OF TYPE-BETA TRANSFORMING GROWTH-FACTOR BY ACTIVATED HUMAN MACROPHAGES [J].
ASSOIAN, RK ;
FLEURDELYS, BE ;
STEVENSON, HC ;
MILLER, PJ ;
MADTES, DK ;
RAINES, EW ;
ROSS, R ;
SPORN, MB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (17) :6020-6024
[3]   INTERLEUKINS AND IGA SYNTHESIS - HUMAN AND MURINE INTERLEUKIN-6 INDUCE HIGH-RATE IGA SECRETION IN IGA-COMMITTED B-CELLS [J].
BEAGLEY, KW ;
ELDRIDGE, JH ;
LEE, F ;
KIYONO, H ;
EVERSON, MP ;
KOOPMAN, WJ ;
HIRANO, T ;
KISHIMOTO, T ;
MCGHEE, JR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (06) :2133-2148
[4]  
BEAGLEY KW, 1988, J IMMUNOL, V141, P2035
[5]   TRANSFORMING GROWTH FACTOR-BETA-1 (TGF-BETA-1) IS A BIFUNCTIONAL IMMUNE REGULATOR FOR MUCOSAL IGA RESPONSES [J].
CHEN, SS ;
QING, L .
CELLULAR IMMUNOLOGY, 1990, 128 (02) :353-361
[6]   TRANSFORMING GROWTH FACTOR-BETA SPECIFICALLY ENHANCES IGA PRODUCTION BY LIPOPOLYSACCHARIDE-STIMULATED MURINE LYMPHOCYTES-B [J].
COFFMAN, RL ;
LEBMAN, DA ;
SHRADER, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (03) :1039-1044
[7]   HUMAN TRANSFORMING GROWTH FACTOR-BETA COMPLEMENTARY-DNA SEQUENCE AND EXPRESSION IN NORMAL AND TRANSFORMED-CELLS [J].
DERYNCK, R ;
JARRETT, JA ;
CHEN, EY ;
EATON, DH ;
BELL, JR ;
ASSOIAN, RK ;
ROBERTS, AB ;
SPORN, MB ;
GOEDDEL, DV .
NATURE, 1985, 316 (6030) :701-705
[8]   PRODUCTION OF A MONOCLONAL-ANTIBODY USEFUL IN THE MOLECULAR CHARACTERIZATION OF MURINE T-CELL-REPLACING FACTOR B-CELL GROWTH FACTOR-II [J].
HARADA, N ;
TAKAHASHI, T ;
MATSUMOTO, M ;
KINASHI, T ;
OHARA, J ;
KIKUCHI, Y ;
KOYAMA, N ;
SEVERINSON, E ;
YAOITA, Y ;
HONJO, T ;
YAMAGUCHI, N ;
TOMINAGA, A ;
TAKATSU, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (13) :4581-4585
[9]  
HARRIMAN GR, 1988, J IMMUNOL, V140, P3033
[10]  
HITOSHI Y, 1990, J IMMUNOL, V144, P4218